Psyched Wellness Ltd. (PSYCF)
For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Psyched Wellness Ltd. (PSYCF) with AI Score 55/100 (Hold). Psyched Wellness Ltd. operates in the health supplements market, focusing on the production and distribution of medicinal mushroom-based consumer packaged goods. Market cap: 0, Sector: Consumer defensive.
Last analyzed: Mar 17, 2026Psyched Wellness Ltd. (PSYCF) Consumer Business Overview
Psyched Wellness Ltd. is a health supplements company specializing in artisanal, medicinal mushroom products, notably Amanita Muscaria Tincture, targeting the consumer packaged goods market within the Consumer Defensive sector. The company aims to provide natural solutions for stress relief and improved sleep, differentiating itself through unique mushroom-based formulations.
Investment Thesis
Psyched Wellness Ltd. presents a speculative investment opportunity within the emerging market for medicinal mushroom-based health supplements. The company's focus on Amanita Muscaria Tincture, positioned as a natural stress-relief and sleep aid, aligns with growing consumer interest in alternative wellness solutions. However, the company's negative profit margin of -1230.8% and gross margin of -46.3% indicate significant challenges in achieving profitability. Growth catalysts include potential regulatory approvals for its products and expansion into new markets. Key risks include competition from established players in the health supplements industry and uncertainties surrounding the regulatory landscape for Amanita Muscaria. Investors should carefully consider the company's financial performance, market position, and regulatory risks before making investment decisions. The company's beta of 0.96 suggests a market risk level close to the overall market.
Based on FMP financials and quantitative analysis
Key Highlights
- Market capitalization of $0.00B indicates a micro-cap company with limited financial resources.
- Negative P/E ratio of -0.98 reflects current losses and the absence of positive earnings.
- Profit margin of -1230.8% highlights significant operational inefficiencies and challenges in achieving profitability.
- Gross margin of -46.3% indicates that the cost of goods sold exceeds revenue, posing a major concern for the company's financial sustainability.
- Beta of 0.96 suggests the stock's price is slightly less volatile than the overall market.
Competitors & Peers
Strengths
- Unique product offering based on medicinal mushrooms.
- Focus on the growing market for natural health supplements.
- Potential for intellectual property protection.
- Experienced management team in the health and wellness industry.
Weaknesses
- Limited financial resources and market capitalization.
- Negative profit margins and gross margins.
- Dependence on a single product (Amanita Muscaria Tincture).
- Lack of established brand recognition.
Catalysts
- Upcoming: Potential regulatory approvals for Amanita Muscaria Tincture in key markets.
- Ongoing: Expansion of distribution network through partnerships with retailers and online marketplaces.
- Ongoing: Product line diversification with new mushroom-based formulations.
- Ongoing: Positive research findings validating the efficacy of its products.
- Ongoing: Increasing consumer awareness of the benefits of medicinal mushrooms.
Risks
- Potential: Competition from established players in the health supplements industry.
- Potential: Regulatory uncertainties surrounding Amanita Muscaria.
- Potential: Negative publicity or safety concerns related to mushroom-based products.
- Potential: Economic downturn affecting consumer spending on discretionary health products.
- Ongoing: Limited financial resources and market capitalization.
Growth Opportunities
- Expansion into new markets: Psyched Wellness can pursue growth by expanding its distribution network to reach new geographic markets. This could involve partnerships with retailers, online marketplaces, and distributors in regions where there is growing demand for natural health supplements. The global health and wellness market is estimated to be worth trillions of dollars, providing ample opportunity for expansion. Timeline: Ongoing.
- Product line diversification: The company can diversify its product line by developing new formulations and delivery methods for its mushroom-based ingredients. This could include capsules, powders, teas, and other consumer-friendly formats. Expanding the product line can attract a wider range of customers and increase revenue streams. The market for functional foods and beverages is experiencing rapid growth, driven by consumer interest in health and wellness. Timeline: Ongoing.
- Strategic partnerships: Psyched Wellness can form strategic partnerships with complementary businesses, such as wellness centers, health food stores, and online retailers. These partnerships can provide access to new customers, distribution channels, and marketing resources. Collaborations with research institutions can also help to validate the efficacy of its products and enhance its credibility. Timeline: Ongoing.
- E-commerce and direct-to-consumer sales: The company can invest in its e-commerce platform and direct-to-consumer sales channels to reach customers directly and build brand loyalty. This can involve targeted online advertising, social media marketing, and email campaigns. The e-commerce market for health and wellness products is growing rapidly, providing a significant opportunity for Psyched Wellness. Timeline: Ongoing.
- Research and development: Continued investment in research and development is crucial for validating the efficacy and safety of Psyched Wellness' products. This can involve clinical trials, scientific studies, and collaborations with research institutions. Positive research findings can enhance the company's credibility, attract new customers, and support regulatory approvals. Timeline: Ongoing.
Opportunities
- Expansion into new markets and distribution channels.
- Product line diversification.
- Strategic partnerships with complementary businesses.
- Increasing consumer awareness of the benefits of medicinal mushrooms.
Threats
- Competition from established players in the health supplements industry.
- Regulatory uncertainties surrounding Amanita Muscaria.
- Potential negative publicity or safety concerns related to mushroom-based products.
- Economic downturn affecting consumer spending on discretionary health products.
Competitive Advantages
- Proprietary formulations of mushroom-based supplements.
- Brand recognition in the niche market of medicinal mushroom products.
- Potential intellectual property protection for its unique products and processes.
- First-mover advantage in the emerging market for Amanita Muscaria-based supplements.
About PSYCF
Psyched Wellness Ltd., formerly known as Duncan Park Holdings Corporation, was incorporated in 2019 and rebranded in July 2020 to focus on the burgeoning market for health supplements derived from medicinal mushrooms. Based in Toronto, Canada, the company is engaged in the production and distribution of artisanal consumer packaged goods centered around these unique ingredients. Their flagship product, Amanita Muscaria Tincture, is marketed for its potential to soothe the body, alleviate physical distress, reduce stress, ease muscular tension, and promote restorative sleep. The company's strategic focus is on developing and commercializing products that leverage the purported health benefits of Amanita Muscaria and other medicinal mushrooms. Psyched Wellness aims to establish itself as a leading provider of natural health solutions within the consumer packaged goods segment. The company's operations encompass sourcing, processing, and packaging of mushroom-based ingredients, as well as marketing and distribution to reach its target consumer base. As a relatively young company, Psyched Wellness is in the early stages of building its brand and establishing its market presence in the competitive health supplements industry. The company manages 1800 employees.
What They Do
- Produces artisanal, medicinal mushroom products.
- Focuses on health supplements.
- Offers Amanita Muscaria Tincture.
- Aims to provide natural solutions for stress relief.
- Markets products to promote restorative sleep.
- Engages in the distribution of consumer packaged goods.
Business Model
- Develops and manufactures health supplements based on medicinal mushrooms.
- Markets and distributes products through various channels, potentially including online sales and retail partnerships.
- Generates revenue through the sale of its Amanita Muscaria Tincture and other mushroom-based products.
Industry Context
Psyched Wellness Ltd. operates within the Consumer Defensive sector, specifically in the Packaged Foods industry. This sector is generally considered stable, as demand for food and health-related products tends to remain consistent regardless of economic conditions. However, the market for medicinal mushroom-based supplements is relatively new and rapidly evolving. The company faces competition from established players in the broader health supplements industry, as well as emerging companies focused on similar niche markets. The industry is subject to regulatory scrutiny, particularly regarding the safety and efficacy of novel ingredients like Amanita Muscaria.
Key Customers
- Individuals seeking natural stress relief and relaxation aids.
- Consumers interested in alternative health and wellness solutions.
- Customers looking for products to promote restorative sleep.
- Health-conscious individuals seeking natural supplements.
Financials
Chart & Info
Psyched Wellness Ltd. (PSYCF) stock price: Price data unavailable
Latest News
No recent news available for PSYCF.
Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for PSYCF.
Price Targets
Wall Street price target analysis for PSYCF.
MoonshotScore
What does this score mean?
The MoonshotScore rates PSYCF's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Jeffrey James Stevens
CEO
Jeffrey James Stevens serves as the CEO of Psyched Wellness Ltd., overseeing the company's strategic direction and operations. His background includes experience in managing teams and driving growth within the consumer packaged goods sector. He is responsible for leading the company's efforts to develop and commercialize its mushroom-based health supplements. His expertise lies in navigating the complexities of the health and wellness market and building a strong brand presence.
Track Record: Under Jeffrey James Stevens' leadership, Psyched Wellness Ltd. has focused on developing and launching its flagship product, Amanita Muscaria Tincture. He has overseen the company's efforts to establish its brand and expand its distribution network. His tenure has been marked by a focus on innovation and a commitment to providing natural health solutions to consumers.
PSYCF OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Psyched Wellness Ltd. may not meet the minimum financial or disclosure requirements for higher tiers like OTCQB or OTCQX. Companies in this tier often have limited trading volume and may not be subject to the same level of regulatory oversight as companies listed on major exchanges like the NYSE or NASDAQ. Investing in companies on the OTC Other tier carries significant risks due to the potential for limited information and liquidity.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited regulatory oversight compared to major exchanges.
- Potential for low trading volume and illiquidity.
- Higher risk of fraud or manipulation.
- Limited availability of financial information and disclosures.
- Greater price volatility.
- Verify the company's registration and legal standing.
- Review available financial statements and disclosures.
- Assess the company's business model and competitive landscape.
- Evaluate the management team's experience and track record.
- Understand the risks associated with investing in OTC stocks.
- Monitor trading volume and price volatility.
- Consult with a financial advisor.
- Company's registration with regulatory authorities.
- Presence of a professional management team.
- Development and launch of a tangible product (Amanita Muscaria Tincture).
- Active engagement with investors and the public.
- Positive media coverage or industry recognition.
Psyched Wellness Ltd. Stock: Key Questions Answered
What does Psyched Wellness Ltd. do?
Psyched Wellness Ltd. is a health supplements company focused on the production and distribution of artisanal, medicinal mushroom products. Its primary offering is Amanita Muscaria Tincture, marketed for its potential to soothe the body, reduce stress, and promote restorative sleep. The company operates within the consumer packaged goods segment of the Consumer Defensive sector, aiming to provide natural wellness solutions to health-conscious consumers. Psyched Wellness is working to establish itself in the emerging market for mushroom-based health supplements.
What do analysts say about PSYCF stock?
Currently, there is no readily available analyst coverage for Psyched Wellness Ltd. (PSYCF) due to its OTC listing and micro-cap status. Key valuation metrics such as P/E ratio (-0.98) and profit margin (-1230.8%) indicate that the company is not yet profitable. Investors should conduct their own thorough research and consider the company's financial performance, growth potential, and risk factors before making any investment decisions. The absence of analyst consensus highlights the speculative nature of this investment.
What are the main risks for PSYCF?
Psyched Wellness Ltd. faces several key risks, including intense competition from established players in the health supplements industry, regulatory uncertainties surrounding Amanita Muscaria, and potential negative publicity related to mushroom-based products. The company's limited financial resources and negative profit margins also pose significant challenges. As an OTC-listed stock, PSYCF is subject to greater price volatility and liquidity risks compared to stocks listed on major exchanges. Investors should carefully assess these risks before considering an investment in Psyched Wellness.
What are the key factors to evaluate for PSYCF?
Psyched Wellness Ltd. (PSYCF) currently holds an AI score of 55/100, indicating moderate score. Key strength: Unique product offering based on medicinal mushrooms.. Primary risk to monitor: Potential: Competition from established players in the health supplements industry.. This is not financial advice.
How frequently does PSYCF data refresh on this page?
PSYCF prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven PSYCF's recent stock price performance?
Recent price movement in Psyched Wellness Ltd. (PSYCF) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Unique product offering based on medicinal mushrooms.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Should investors consider PSYCF overvalued or undervalued right now?
Determining whether Psyched Wellness Ltd. (PSYCF) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.
What research should beginners do before buying PSYCF?
Before investing in Psyched Wellness Ltd. (PSYCF), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Information is based on available data and may be subject to change.
- OTC stocks carry higher risks than exchange-listed stocks.